CNBX Pharmaceutical (CNBX) Debt by Year
CNBX Pharmaceutical Inc held $15K in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters CNBX Pharmaceutical Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CNBX Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $15K-42.8% | $26K-79.6% | $130K+10.4% | $118K-91.5% | $1.4M+78.3% | $778K+192.4% | $266K-80.9% | $1.4M0.0% | $1.4M+7186.1% | $19K-24.2% | $25K-74.5% | $99Kn/m | $0n/m | $0n/m | $0 |
CNBX Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $9K-30.5% | $12K-73.4% | $8K-55.6% | $15K-42.8% | $14K-81.4% | $46K+23.0% | $17K-78.8% | $26K-79.6% | $73K+66.3% | $37K-22.2% | $82K+278.0% | $130K+10.4% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More CNBX Pharmaceutical Inc financials
Frequently Asked Questions
CNBX Pharmaceutical Inc held $15K in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what CNBX Pharmaceutical Inc (CNBX) reported on that line in every period on record.